Lupin gets US FDA approval for generic version of Doxycycline Hyclate tablets

Doxycycline Hyclate Delayed-Release Tablets USP had estimated annual sales of $9 million in the US.

Related Keywords

India ,United States , ,Drug Administration ,Lupin Digital Health ,United States Food ,Doxycycline Hyclate Delayed Release ,Doxycycline Hyclate Delayed Release Tablets ,Doryx Delayed Release Tablets ,Release Tablets ,Us Fda ,Lupin ,Generic Drug ,